Serum cathepsin K levels of patients with longstanding rheumatoid arthritis: correlation with radiological destruction.
about
Novel biological markers of bone: from bone metabolism to bone physiologyOvine model for critical-size tibial segmental defects.The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now?Biomarkers for osteoporosis management: utility in diagnosis, fracture risk prediction and therapy monitoring.Future of anticathepsin K drugs: dual therapy for skeletal disease and atherosclerosis?Osteoporosis--a risk factor for cardiovascular disease?Are biological targets the final goal for rheumatoid arthritis therapy?Biochemical markers of bone turnover - uses and limitations.The Roles of Lysosomes in Inflammation and Autoimmune Diseases.The Utility of Biomarkers in Osteoporosis Management.Assessment of murine collagen-induced arthritis by longitudinal non-invasive duplexed molecular optical imaging.Chemical introduction of the green fluorescence: imaging of cysteine cathepsins by an irreversibly locked GFP fluorophore.Cathepsin K levels in the crevicular fluid of dental implants: a pilot study.Effect of a cathepsin K inhibitor on arthritis and bone mineral density in ovariectomized rats with collagen-induced arthritis.Serum cysteine proteases and their inhibitors in rheumatoid arthritis: relation to disease activity and radiographic progressionLow-Dose Radiotherapy Ameliorates Advanced Arthritis in hTNF-α tg Mice by Particularly Positively Impacting on Bone MetabolismEfficacy of calcium supplementation for human bone health by mass spectrometry profiling and cathepsin K measurement in plasma samples
P2860
Q28067712-32EE3BDF-07D1-45BA-88A6-CA0DD37BCA97Q34539379-D1109500-6A96-4E36-9399-189DFEED66AEQ36790324-DA015598-D6E3-45A6-9923-116D4811FB19Q37176381-39721F88-3CD6-4A77-A980-538D923B11E0Q37428071-36C6AFF1-7263-4696-96F3-6777B08A0450Q38034388-7D3FB061-84BA-4D31-B57F-E63F4F5EDD5EQ38041208-7EA92352-7631-4F1F-A7D9-76299CA46BAFQ38176560-40332E30-575E-4EF7-A1B4-CE9EA1FA2D0FQ38235294-BAA14FB4-C5B1-45E0-A2E5-BF3A8CA8C686Q38921875-E0A19112-5103-44A9-A7BE-A3B2FAA202F9Q40948096-E2151A85-683D-4BDE-84FF-EFEBADA62269Q47867122-12EE95E6-F925-4138-886C-38C90A2E3D21Q51242983-FF86F85E-8FC8-4162-87FF-3999977AE20FQ55506744-CE5A97B7-7820-4CEA-8B28-B5EE5D7D1457Q56974060-1644A4F1-E17F-4852-8269-97063C0791AFQ57073728-E18358E3-CA2D-4BD4-9EEC-C1BF5F0B0DDCQ57219481-FBBEE080-5E10-4DCA-8124-E592490E0671
P2860
Serum cathepsin K levels of patients with longstanding rheumatoid arthritis: correlation with radiological destruction.
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Serum cathepsin K levels of pa ...... with radiological destruction
@nl
Serum cathepsin K levels of pa ...... with radiological destruction.
@ast
Serum cathepsin K levels of pa ...... with radiological destruction.
@en
type
label
Serum cathepsin K levels of pa ...... with radiological destruction
@nl
Serum cathepsin K levels of pa ...... with radiological destruction.
@ast
Serum cathepsin K levels of pa ...... with radiological destruction.
@en
prefLabel
Serum cathepsin K levels of pa ...... with radiological destruction
@nl
Serum cathepsin K levels of pa ...... with radiological destruction.
@ast
Serum cathepsin K levels of pa ...... with radiological destruction.
@en
P2093
P2860
P356
P1476
Serum cathepsin K levels of pa ...... with radiological destruction.
@en
P2093
Anton Klingler
Gerhard Hawa
Gernot Kolarz
Günther Haberhauer
Martin Skoumal
Wolfgang Woloszczuk
P2860
P2888
P304
P356
10.1186/AR1461
P407
P577
2004-11-10T00:00:00Z
P5875
P6179
1027264904